{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:36:13Z","timestamp":1778657773699,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s11908-011-0183-y","type":"journal-article","created":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T01:39:46Z","timestamp":1301535586000},"page":"243-247","source":"Crossref","is-referenced-by-count":23,"title":["TNF-\u03b1 Antagonists and Immunization"],"prefix":"10.1007","volume":"13","author":[{"given":"Leo G.","family":"Visser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,1]]},"reference":[{"key":"183_CR1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","volume":"3","author":"BB Aggarwal","year":"2003","unstructured":"Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3:745\u201356.","journal-title":"Nat Rev Immunol"},{"key":"183_CR2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nri2526","volume":"9","author":"M Croft","year":"2009","unstructured":"Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol. 2009;9:271\u201385.","journal-title":"Nat Rev Immunol"},{"key":"183_CR3","unstructured":"Murphy KM, Travers P, Walport M. Janeway\u2019s immunobiology. 7th ed. November 2007 page 383"},{"key":"183_CR4","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/jps.20178","volume":"93","author":"ED Lobo","year":"2004","unstructured":"Lobo ED, Hansen RJ, Balthasar JP. Antibody pharmacokinetics and pharmacodynamics. J Pharm Sci. 2004;93:2645\u201368.","journal-title":"J Pharm Sci"},{"key":"183_CR5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","volume":"117","author":"D Tracey","year":"2008","unstructured":"Tracey D, Klareskog L, Sasso E, et al. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 2008;117:244\u201379.","journal-title":"Pharmacol Ther"},{"key":"183_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04146.x","volume":"161","author":"J Harris","year":"2010","unstructured":"Harris J, Keane J. How tumour necrosis factor blockers interfere with tuberculosis immunity. Clin Exp Immunol. 2010;161:1\u20139.","journal-title":"Clin Exp Immunol"},{"key":"183_CR7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(08)70227-5","volume":"8","author":"RS Wallis","year":"2008","unstructured":"\u2022\u2022 Wallis RS. Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. Lancet Infect Dis. 2008;8:601\u201311. This review elucidates why soluble TNFR and TNF monoclonal antibodies have a different effect on the granulomatous infections, such as tuberculosis.","journal-title":"Lancet Infect Dis"},{"key":"183_CR8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/ncprheum0438","volume":"3","author":"WFC Rigby","year":"2007","unstructured":"Rigby WFC. Drug insight: different mechanisms of action of tumour necrosis factor antagonists\u2014passive-aggressive behaviour? Nat Clin Pract Rheumatol. 2007;3:227\u201333.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"183_CR9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1172\/JCI2676","volume":"102","author":"L Genestier","year":"1998","unstructured":"Genestier L, Paillot R, Fournel S, et al. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest. 1998;102:322\u20138.","journal-title":"J Clin Invest"},{"key":"183_CR10","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1517\/14712598.8.11.1787","volume":"8","author":"AH Roukens","year":"2008","unstructured":"Roukens AH, Visser LG. Yellow fever vaccine: past, present and future. Expert Opin Biol Ther. 2008;8:1787\u201395.","journal-title":"Expert Opin Biol Ther"},{"key":"183_CR11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/acr.20045","volume":"62","author":"M Scheinberg","year":"2010","unstructured":"Scheinberg M, Guedes-Barbosa LS, Mangueira C, et al. Yellow fever revaccination during infliximab therapy. Arthritis Care Res (Hoboken). 2010;62:896\u201388.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"183_CR12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1756-185X.2010.01466.x","volume":"13","author":"H Badsha","year":"2010","unstructured":"Badsha H, Daher M, Edwards CJ. Live polio vaccine exposure while receiving anti-TNF therapy for reactive arthritis. Int J Rheum Dis. 2010;13:184\u201396.","journal-title":"Int J Rheum Dis"},{"key":"183_CR13","first-page":"2500","volume":"32","author":"E Toussirot","year":"2005","unstructured":"Toussirot E, Wendling D. Bacillus calmette-gu\u00e9rin vaccination in a patient treated with infliximab. J Rheumatol. 2005;32:2500\u20131.","journal-title":"J Rheumatol"},{"key":"183_CR14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/ken436","volume":"48","author":"S Borte","year":"2009","unstructured":"Borte S, Liebert UG, Borte M, et al. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatol (Oxford). 2009;48:144\u20138.","journal-title":"Rheumatol (Oxford)"},{"issue":"4","key":"183_CR15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.semarthrit.2003.10.003","volume":"33","author":"O Elkayam","year":"2004","unstructured":"Elkayam O, Caspi D, Reitblatt T, et al. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum. 2004;33(4):283\u20138.","journal-title":"Semin Arthritis Rheum"},{"key":"183_CR16","first-page":"1356","volume":"31","author":"PJ Mease","year":"2004","unstructured":"Mease PJ, Ritchlin CT, Martin RW, et al. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol. 2004;31:1356\u201361.","journal-title":"J Rheumatol"},{"key":"183_CR17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","volume":"45","author":"MC Kapetanovic","year":"2006","unstructured":"Kapetanovic MC, Saxne T, Sj\u00f6holm A, et al. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatol (Oxford). 2006;45:106\u201311.","journal-title":"Rheumatol (Oxford)"},{"key":"183_CR18","first-page":"272","volume":"34","author":"JL Kaine","year":"2007","unstructured":"Kaine JL, Kivitz AJ, Birbara C, et al. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol. 2007;34:272\u20139.","journal-title":"J Rheumatol"},{"key":"183_CR19","first-page":"952","volume":"34","author":"S Visvanathan","year":"2007","unstructured":"Visvanathan S, Keenan GF, Baker DG, et al. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J Rheumatol. 2007;34:952\u20137.","journal-title":"J Rheumatol"},{"key":"183_CR20","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1016\/j.vaccine.2008.04.028","volume":"26","author":"LBS Gelinck","year":"2008","unstructured":"Gelinck LBS, van der Bijl AE, Visser LG, et al. Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody response to the 23-valen pneumococcal polysaccharide vaccine. Vaccine. 2008;26:3528\u201333.","journal-title":"Vaccine"},{"key":"183_CR21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/ard.2005.036434","volume":"65","author":"I Fomin","year":"2006","unstructured":"Fomin I, Caspi D, Levy V, et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis. 2006;65:191\u20134.","journal-title":"Ann Rheum Dis"},{"key":"183_CR22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/rheumatology\/kel366","volume":"46","author":"MC Kapetanovic","year":"2007","unstructured":"Kapetanovic MC, Saxne T, Nilsson JA, et al. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatol (Oxford). 2007;46:608\u201311.","journal-title":"Rheumatol (Oxford)"},{"key":"183_CR23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cgh.2007.02.035","volume":"5","author":"P Mamula","year":"2007","unstructured":"Mamula P, Markowitz JE, Piccoli DA, et al. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:851\u20136.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"183_CR24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.2007.077552","volume":"67","author":"LB Gelinck","year":"2008","unstructured":"Gelinck LB, van der Bijl AE, Beyer WE, et al. The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis. 2008;67:713\u2013176.","journal-title":"Ann Rheum Dis"},{"key":"183_CR25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.semarthrit.2008.12.002","volume":"39","author":"O Elkayam","year":"2010","unstructured":"Elkayam O, Bashkin A, Mandelboim M, et al. The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum. 2010;39:442\u20137.","journal-title":"Semin Arthritis Rheum"},{"key":"183_CR26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.clim.2009.09.014","volume":"134","author":"S Salemi","year":"2010","unstructured":"Salemi S, Picchianti-Diamanti A, Germano V, et al. Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity. Clin Immunol. 2010;134:113\u201320.","journal-title":"Clin Immunol"},{"key":"183_CR27","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1016\/j.vaccine.2010.03.080","volume":"28","author":"E Farmaki","year":"2010","unstructured":"Farmaki E, Kanakoudi-Tsakalidou F, Spoulou V, et al. The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis. Vaccine. 2010;28:5109\u201313.","journal-title":"Vaccine"},{"key":"183_CR28","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/rheumatology\/keq183","volume":"49","author":"JF Rahier","year":"2010","unstructured":"\u2022\u2022 Rahier JF, Moutschen M, Van Gompel A, et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatol (Oxford). 2010;49:1815\u201327. This article provides a very practical review on recurrent issues of vaccination in patients with autoimmune inflammatory disease.","journal-title":"Rheumatol (Oxford)"},{"key":"183_CR29","doi-asserted-by":"crossref","unstructured":"\u2022 van Assen S, Elkayam O, Agmon-Levin N, et al. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European league against rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev. 2010 Dec 20. [Epub ahead of print]. This article is a very comprehensive systematic review on infection risks and efficacy of vaccination in patients with rheumatic disease.","DOI":"10.1016\/j.autrev.2010.12.003"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-011-0183-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-011-0183-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-011-0183-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T23:40:18Z","timestamp":1686008418000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-011-0183-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,1]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1007\/s11908-011-0183-y","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,1]]}}}